Trial Profile
Effect of rosuvastatin monotherapy and in combination with fenofibrate or omega-3 fatty acids on serum vitamin D levels.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2013
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Fenofibrate; Omega 3 fatty acids
- Indications Dyslipidaemias
- Focus Pharmacodynamics
- 06 Sep 2012 New trial record
- 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.